FBL-MTX / Solfarcos - LARVOL DELTA

Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis (clinicaltrials.gov) - P2 | N=40 | Recruiting | Sponsor: SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd

New P2 trial • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology • CRP